| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility. | Blood | 2008 | 1.98 |
| 2 | MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer. | Int J Cancer | 2008 | 1.08 |
| 3 | A functional variant in the core promoter of the CD95 cell death receptor gene predicts prognosis in acute promyelocytic leukemia. | Blood | 2011 | 0.89 |
| 4 | A common genetic variant in XPD associates with risk of 5q- and 7q-deleted acute myeloid leukemia. | Blood | 2006 | 0.81 |
| 5 | Non-homologous end-joining gene profiling reveals distinct expression patterns associated with lymphoma and multiple myeloma. | Br J Haematol | 2010 | 0.79 |
| 6 | Genetic variation in genes expressed in the germinal center and risk of B cell lymphoma among Caucasians. | Haematologica | 2008 | 0.79 |
| 7 | RAG1 and BRCA2 polymorphisms in non-Hodgkin lymphoma. | Blood | 2007 | 0.76 |